Medicare Enrolled

Dr. Obinna Uzodinma, M.D.

Pain Medicine · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
12222 MERIT DR STE 600, Dallas, TX 75251
9727155000
Registered in NPPES since 2010
NPI: 1841521812 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Uzodinma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Uzodinma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Uzodinma

Dr. Obinna Uzodinma is a pain medicine specialist in Dallas, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Uzodinma performed 26 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Uzodinma received a total of $12,795 from 61 pharmaceutical and/or device companies across 550 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Uzodinma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration ▲ 26 Medicare services $12,795 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
26
Medicare services
Bottom 9% in TX for pain medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$130
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Anesthesia for colonoscopy
Administration of anesthesia during an examination of the colon using an endoscope.
14 $117 $1,900
Anesthesia for bowel endoscopy
Administration of anesthesia during a procedure to examine the small and large bowel using an endoscope.
12 $144 $1,992
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2022 ↗
$12,795
Total received (2018-2022)
Avg $2,559/year across 5 years
Top 15% in TX for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
550
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$396
2021
$3,380
2020
$2,411
2019
$3,072
2018
$3,535

Payments by company (2022)

ABBVIE INC.
$72
Lundbeck LLC
$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$65
Amgen Inc.
$27
Biohaven Pharmaceutical Holding Company Ltd.
$23
Fidia Pharma USA Inc.
$23
Lilly USA, LLC
$21
Supernus Pharmaceuticals, Inc.
$20
Teva Pharmaceuticals USA, Inc.
$20
Medtronic, Inc.
$17
Horizon Therapeutics plc
$17
GRT US Holding, Inc.
$16
Epimed International, Inc
$7
Top 3 companies account for 52.0% of 2022 payments
All-time payments by company (2018-2022) ›
Abbott Laboratories
$1,467
Medtronic USA, Inc.
$1,419
RedHill Biopharma Inc.
$984
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$922
Nevro Corp.
$911
Collegium Pharmaceutical, Inc.
$746
Supernus Pharmaceuticals, Inc.
$610
Medtronic, Inc.
$505
Daiichi Sankyo Inc.
$372
Teva Pharmaceuticals USA, Inc.
$348
BioDelivery Sciences International, Inc.
$342
Boston Scientific Corporation
$325
BOSTON SCIENTIFIC CORPORATION
$248
AbbVie Inc.
$241
GRT US Holding, Inc.
$176
AstraZeneca Pharmaceuticals LP
$173
Novartis Pharmaceuticals Corporation
$171
PFIZER INC.
$169
Scilex Pharmaceuticals Inc.
$165
ASSERTIO THERAPEUTICS, Inc.
$161
Horizon Therapeutics plc
$155
Allergan Inc.
$141
Amgen Inc.
$130
TerSera Therapeutics LLC
$123
ARBOR PHARMACEUTICALS, INC.
$121
Flexion Therapeutics, Inc.
$116
SCILEX PHARMACEUTICALS INC.
$114
SI-BONE, Inc.
$112
Kaleo, Inc.
$107
Sentynl Therapeutics, Inc.
$94
Biohaven Pharmaceuticals, Inc.
$85
ABBVIE INC.
$72
Lundbeck LLC
$69
Merz North America, Inc.
$65
Lilly USA, LLC
$62
FIDIA PHARMA USA INC.
$62
Shionogi Inc
$54
West Therapeutics Development, LLC
$53
Eisai Inc.
$48
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$48
Bioventus LLC
$47
Purdue Pharma L.P.
$43
Egalet US Inc
$42
Horizon Pharma plc
$39
Arbor Pharmaceuticals, Inc.
$39
Allergan, Inc.
$35
US WorldMeds, LLC
$29
Pernix Therapeutics Holdings, Inc.
$27
Biohaven Pharmaceutical Holding Company Ltd.
$23
Fidia Pharma USA Inc.
$23
INSYS Therapeutics Inc
$22
Assertio Therapeutics, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$19
Zyla Life Sciences
$17
Vertical Pharmaceuticals, LLC
$15
Almatica Pharma LLC
$15
Zyla Life Sciences, Inc.
$14
IBSA Pharma Inc.
$13
Electronic Waveform Lab, Inc.
$12
Takeda Pharmaceuticals U.S.A., Inc.
$11
Epimed International, Inc
$7
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · ARYMO ER · Aimovig · Amitiza · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Cambia · Catheter and Needle · DUEXIS · Dayvigo · Durolane · EMGALITY · ENTRADA · EVZIO · Evzio · Flector · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · Gralise · Horizant · Hymovis · INTELLIS · LORZONE · LUCEMYRA · LYRICA · Lazanda · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · OXTELLAR XR · Omnia · PENNSAID · PRIALT · Proclaim Family of SCS IPGs · Prodigy Family of SCS IPGs · Protege Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · SPECTRA WAVEWRITER · SPRIX · SUBSYS · SYMPROIC · SYNCHROMED · SYNVISC-ONE · Senza Spinal Cord Stimulation System · Symproic · TRILURON · TROKENDI XR · UBRELVY · V-Loc · VYEPTI · XEOMIN · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · movantik · talicia
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pain medicine specialist in Dallas?
Compare pain medicines in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines in nearby ZIP areas
13
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY GREEN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Uzodinma is a mixed practice specialist, with moderate Medicare volume, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Uzodinma experienced with anesthesia for colonoscopy?
Based on Medicare claims data, Dr. Uzodinma performed 14 anesthesia for colonoscopy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Uzodinma receive payments from pharmaceutical companies?
Yes. Dr. Uzodinma received a total of $12,795 from 61 companies across 550 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Uzodinma's costs compare to other pain medicines in Dallas?
Dr. Uzodinma's average Medicare payment per service is $130. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Uzodinma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →